DESIGN OF EXPERT-BASED ECO-FRIENDLY RP-HPLC ANALYTICAL METHOD FOR THE ESTIMATION OF LUMEFANTRINE FROM THE CARBON DOTS
DOI:
https://doi.org/10.22159/ijap.2026v18i1.54769Keywords:
Malaria, Lumefantrine, HPLC, Design of expert, Carbon dotsAbstract
Objective: The most common and lethal malaria-causing species in humans, Plasmodium falciparum and Plasmodium vivax, are caused by protozoan parasites belonging to the genus Plasmodium. Due to the substantial therapeutic obstacles posed by these parasites, novel therapy strategies are being investigated. By improving the solubility and cellular absorption of antimalarial drugs, including lumefantrine (LUM), carbon dots (CDs), a new nanomaterial, hold promise for the management of malaria. In order to evaluate the stability, drug release profile, and percentage entrapment efficiency (%EE) of LUM-loaded CDs and support their potential for the treatment of malaria, this study set out to design and validate an analytical approach based on HPLC.
Methods: A Design of Experiments (DoE) strategy was employed to optimize the HPLC process, systematically altering the injection volume, flow rate, buffer ratio, and buffer pH to improve performance. The following responses were tracked: theoretical plates (Tp), tailing factor (Tf), drug peak area, and retention time (RT). Following the requirements of ICH Q2(R2), linearity was established for LUM throughout a range of 0.5 to 20 µg/ml.
Results: The result was a linear regression equation with an R2>0.999, demonstrating strong linearity. For both intra-day and inter-day studies, the method's precision with a %CV<2% and accuracy between 98 and 102% ensured repeatability when used for evaluating LUM stability, %EE, and drug release in CDs. The technique exhibited sensitivity for low concentrations and selectivity, separating LUM from excipients and degradation products. Its eco-friendliness was confirmed with an AGREE score of 0.7, indicating less waste and solvent consumption.
Conclusion: The quantification of LUM in CDs, formulation parameter optimization, and the development of sustainable malaria treatment techniques are all made possible by this verified HPLC approach.
References
1. World Health Organization (WHO) guidelines: WHO. WHO guidelines for malaria. Geneva: World Health Organization; 2025 Aug 13. doi: 10.2471/B09514.
2. Talapko J, Skrlec I, Alebic T, Jukic M, Vcev A. Malaria: the past and the present. Microorganisms. 2019;7(6):179. doi: 10.3390/microorganisms7060179, PMID 31234443.
3. Tuteja R. Malaria an overview. FEBS Journal. 2007;274(18):4670-9. doi: 10.1111/j.1742-4658.2007.05997.x, PMID 17824953.
4. Tse EG, Korsik M, Todd MH. The past present and future of anti-malarial medicines. Malar J. 2019;18(1):93. doi: 10.1186/s12936-019-2724-z, PMID 30902052.
5. Memvanga PB, Nkanga CI. Liposomes for malaria management: the evolution from 1980 to 2020. Malar J. 2021;20(1):327. doi: 10.1186/s12936-021-03858-0, PMID 34315484.
6. Rajora AD, Bal T, Gupta A. Chapter Five. Properties and characterization of eco-friendly carbon dots. In: Hussain CM, Hussain GN, editors. Ecofriendly carbon dots in analytical chemistry: sustainable materials for separation, detection and imaging. Elsevier; 2025. p. 110-21. doi: 10.1016/bs.coac.2024.09.003.
7. Gupta A, Rajora AD, Bal T. Chapter One. Eco-friendly carbon dots: new prospects in analytical chemistry. In: Hussain CM, Hussain GN, editors. Ecofriendly carbon dots in analytical chemistry: sustainable materials for separation, detection and imaging. Elsevier; 2025. p. 1-22. doi: 10.1016/bs.coac.2024.09.001.
8. Gupta A, Rajora AD, Bal T. Chapter Ten-Eco-friendly carbon dots in hydrogels and their applications. In: Ecofriendly carbon dots in analytical chemistry: sustainable materials for separation, detection and imaging. Vol. 108 of Comprehensive Analytical Chemistry. Elsevier; 2025. p. 230–47. doi: 10.1016/bs.coac.2024.09.005.
9. Gopireddy RR, Maruthapillai A, Devikala S, Tamilselvi M, Selvi JA, Mahapatra S. DoE approach: a validated stability indicating RP-HPLC method development for the separation of diasteromeric analogs and process impurities of carfilzomib. Mater Today Proc. 2019;14:514-31. doi: 10.1016/j.matpr.2019.04.174.
10. Gupta A, Kossambe RV, Moorkoth S. Box-behnken design assisted eco-friendly RP-HPLC-PDA method for the quantification of paclitaxel: application to evaluate the solubility of paclitaxel-cyclodextrin complex. Int J Appl Pharm. 2024;16(6):305-15. doi: 10.22159/ijap.2024v16i6.51690.
11. Tome T, Zigart N, Casar Z, Obreza A. Development and optimization of liquid chromatography analytical methods by using AQbD principles: overview and recent advances. Org Process Res Dev. 2019;23(9):1784-802. doi: 10.1021/acs.oprd.9b00238.
12. Gupta A, P, Moorkoth S, Dhas N. Central composite design aided optimization and validation of developed an eco-friendly HPLC method for the quantification of lenalidomide loaded mesoporous silica nanoparticles. J Appl Pharm Sci. 2024;15:89-101. doi: 10.7324/JAPS.2024.189998.
13. Gupta A, Mutalik S, Navti PD, Saha M, Moorkoth S, Shetty S. Box-behnken guided development of an ecofriendly RP-HPLC analytical method for simultaneous quantification of pantoprazole sodium and piperine co-loaded mucoadhesive GRDDS formulation for H. pylori eradication. J Appl Pharm Sci. 2024;14(9):98–110. doi: 10.7324/JAPS.2024.179147.
14. Sarısaltık Yasın D, Arslanturk Bingul A, Karakucuk A, Teksin ZS. Development and validation of an HPLC method using an experimental design for analysis of amlodipine besylate and enalapril maleate in a fixed-dose combination. Turk J Pharm Sci. 2021;18(3):306-18. doi: 10.4274/tjps.galenos.2020.89725, PMID 34157820.
15. Tomikj M, Bozinovska M, Anevska Stojanovska N, Lazova J, Acevska J, Brezovska K. Sustainable and white HPLC method for simultaneous determination of amlodipine and Atorvastatin in film-coated tablet. Green Anal Chem. 2024;8:100103. doi: 10.1016/j.greeac.2024.100103.
16. Gupta A, Rachana SP, Moorkoth S, Dhas N. Quality by design-based eco-friendly HPLC analytical method for simultaneous quantification of erastin and lenalidomide in mesoporous silica nanoparticles. Sci Rep. 2025;15(1):8873. doi: 10.1038/s41598-025-93331-8, PMID 40087405.
17. Mutalik SP, Mullick P, Pandey A, Kulkarni SS, Mutalik S. Box–behnken design aided optimization and validation of developed reverse phase HPLC analytical method for simultaneous quantification of dolutegravir sodium and lamivudine co-loaded in nano-liposomes. J Sep Sci. 2021;44(15):2917-31. doi: 10.1002/jssc.202100152, PMID 34076952.
18. Naik S, Mullick P, Mutalik SP, Hegde AR, Lewis SA, Bhat K. Full factorial design for development and validation of a stability-indicating RP-HPLC method for the estimation of timolol maleate in surfactant-based elastic nano-vesicular systems. J Chromatogr Sci. 2022;60(6):584-94. doi: 10.1093/chromsci/bmab101, PMID 34435614.
19. U.S. Food and Drug Administration (FDA) guidance document: U.S. Food and Drug Administration. Q2(R1) Validation of Analytical Procedures: Text and Methodology Guidance for Industry. Silver Spring (MD): FDA; 2021 Sep 16. Available from: https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/q2r1-validation-analytical-procedures-text-and-methodology-guidance-industry. [Last accessed on 05 Mar 2025].
20. Gupta A, Navti PD, Mutalik S, Saha M, Moorkoth S. DoE guided development of an HPLC method for evaluation of amoxicillin and metronidazole co-loaded mucoadhesive GRDDS formulation for H. pylori eradication. Chromatographia. 2023;86(11-12):729-42. doi: 10.1007/s10337-023-04290-z.
21. Saha M, Gupta A, Shetty S, Mutalik S, Nandakumar K, Raghu Chandrashekar H. DoE-aided optimization of RP-HPLC method for simultaneous estimation of amoxicillin and tinidazole loaded mucoadhesive GRDDS formulation for the treatment of H. pylori. Chromatographia. 2024;87(9):533-48. doi: 10.1007/s10337-024-04346-8.
22. Pena Pereira F, Wojnowski W, Tobiszewski M. AGREE-analytical GREEnness metric approach and software. Anal Chem. 2020;92(14):10076-82. doi: 10.1021/acs.analchem.0c01887, PMID 32538619.
23. Shakeel K, Raisuddin S, Ali S, Imam SS, Rahman MA, Jain GK. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery. J Liposome Res. 2019;29(1):35-43. doi: 10.1080/08982104.2017.1410173, PMID 29179636.
Published
How to Cite
Issue
Section
Copyright (c) 2026 RAKSHA, ASHUTOSH GUPTA, MOUMITA SAHA, SUDHEER MOORKOTH, ABHAY BHARDWAJ, ADITYA DEV RAJORA
This work is licensed under a Creative Commons Attribution 4.0 International License.